Patents by Inventor Amir Berman

Amir Berman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable amorphous calcium carbonate comprising synthetic phosphorylated peptides
    Patent number: 10328100
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: June 25, 2019
    Assignee: AMORPHICAL LTD.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter
  • STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING SYNTHETIC PHOSPHORYLATED PEPTIDES
    Publication number: 20160045546
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Application
    Filed: June 19, 2015
    Publication date: February 18, 2016
    Applicant: AMORPHICAL LTD.
    Inventors: Shmuel BENTOV, Amir SAGI, Amir BERMAN, Assaf SHECHTER
  • ORALLY-ADMINISTRABLE COMPOSITIONS COMPRISING STABLE AMORPHOUS CALCIUM CARBONATE
    Publication number: 20150366903
    Abstract: The present invention provides orally-administrable compositions comprising stable amorphous calcium carbonate (ACC). The compositions are preferably prepared as solid dosage forms such as tablets, capsules and powders. The present invention further provides methods for supplementing oral calcium intake in subjects and as well as methods for treating osteoporosis, osteomalacia and related diseases.
    Type: Application
    Filed: August 28, 2015
    Publication date: December 24, 2015
    Applicant: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventors: Amir SAGI, Amir BERMAN, Yosef BEN
  • Orally-administrable compositions comprising stable amorphous calcium carbonate
    Patent number: 9149494
    Abstract: The present invention provides orally-administrable compositions comprising stable amorphous calcium carbonate (ACC). The compositions are preferably prepared as solid dosage forms such as tablets, capsules and powders. The present invention further provides methods for supplementing oral calcium intake in subjects and as well as methods for treating osteoporosis, osteomalacia and related diseases.
    Type: Grant
    Filed: November 24, 2006
    Date of Patent: October 6, 2015
    Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventors: Amir Sagi, Amir Berman, Yosef Ben
  • Stable amorphous calcium carbonate comprising phosphorylated amino acids
    Patent number: 8802160
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid which stabilizes the amorphous form of said calcium carbonate. The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Grant
    Filed: October 22, 2008
    Date of Patent: August 12, 2014
    Assignee: Amorphical Ltd.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter
  • Biomimetic membranes, their production and uses thereof in water purification
    Publication number: 20110084026
    Abstract: The present invention discloses a water membrane comprising a lipid bilayer supported on a single side thereof on a water permeable dense support layer, this lipid bilayer being composed of one or more lipids and aquaporin proteins are embedded therein, further wherein the water permeable dense support layer is impermeable to the lipids and to the aquaporin proteins. Also are provided a method for the preparation of these membranes and uses thereof in water filtration applications.
    Type: Application
    Filed: June 29, 2010
    Publication date: April 14, 2011
    Applicant: B.G. Negev Technologies Ltd.
    Inventors: Viatcheslav Freger, Amir Berman, Yair Kaufman
  • STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING PHOSPHORYLATED AMINO ACIDS
    Publication number: 20100310677
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid which stabilizes the amorphous form of said calcium carbonate. The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Application
    Filed: October 22, 2008
    Publication date: December 9, 2010
    Applicant: AMORPHICAL LTD.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter
  • STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING SYNTHETIC PHOSPHORYLATED PEPTIDES
    Publication number: 20100221362
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Application
    Filed: April 22, 2010
    Publication date: September 2, 2010
    Applicant: AMORPHICAL LTD.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter
  • Orally-administrable compositions comprising stable amorphous calcium carbonate
    Publication number: 20080199540
    Abstract: The present invention provides orally-administrable compositions comprising stable amorphous calcium carbonate (ACC). The compositions are preferably prepared as solid dosage forms such as tablets, capsules and powders. The present invention further provides methods for supplementing oral calcium intake in subjects and as well as methods for treating osteoporosis, osteomalacia and related diseases.
    Type: Application
    Filed: November 24, 2006
    Publication date: August 21, 2008
    Applicant: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventors: Amir Sagi, Amir Berman, Yosef Ben
  • Growth of oriented crystals at polymerized membranes
    Patent number: 6017390
    Abstract: The present invention relates to methods and compositions for the growth and alignment of crystals at biopolymeric films. The methods and compositions of the present invention provide means to generate a variety of dense crystalline ceramic films, with totally aligned crystals, at low temperatures and pressures, suitable for use with polymer and plastic substrates.
    Type: Grant
    Filed: July 22, 1997
    Date of Patent: January 25, 2000
    Assignee: The Regents of the University of California
    Inventors: Deborah H. Charych, Amir Berman